In patients with invasive aspergillosis, initial therapy with voriconazole led to better responses and improved survival and resulted in fewer severe side effects than the standard approach of initial therapy with amphotericin B [1]. We report a case of life-threatening toxic epidermal necrolysis related with the use of voriconazole in a patient with pulmonary invasive aspergillosis.
Curigliano, G., Formica, V., De Pas, T., Spitaleri, G., Pietri, E., Fazio, N., et al. (2006). Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy [3]. ANNALS OF ONCOLOGY, 17(7), 1174-1175 [10.1093/annonc/mdj126].
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy [3]
Formica, V.;
2006-01-01
Abstract
In patients with invasive aspergillosis, initial therapy with voriconazole led to better responses and improved survival and resulted in fewer severe side effects than the standard approach of initial therapy with amphotericin B [1]. We report a case of life-threatening toxic epidermal necrolysis related with the use of voriconazole in a patient with pulmonary invasive aspergillosis.| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS0923753419453696.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
77.24 kB
Formato
Adobe PDF
|
77.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
